ArticlePharmaceutics2020

Development and Evaluation of a Reconstitutable Dry Suspension Containing Isoniazid for Flexible Pediatric Dosing.

Oluwatoyin A Adeleke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.